Details

The Maudsley Prescribing Guidelines in Psychiatry


The Maudsley Prescribing Guidelines in Psychiatry


13. Aufl.

von: David M. Taylor, Thomas R. E. Barnes, Allan H. Young

59,99 €

Verlag: Wiley-Blackwell
Format: EPUB
Veröffentl.: 14.05.2018
ISBN/EAN: 9781119442585
Sprache: englisch
Anzahl Seiten: 872

DRM-geschütztes eBook, Sie benötigen z.B. Adobe Digital Editions und eine Adobe ID zum Lesen.

Beschreibungen

The revised 13th edition of the essential reference for the prescribing of drugs for patients with mental health disorders The revised and updated 13th edition of The Maudsley Prescribing Guidelines in Psychiatry provides up-to-date information, expert guidance on prescribing practice in mental health, including  drug choice, treatment of adverse effects and how to augment or switch medications. The text covers a wide range of topics including pharmacological interventions for  schizophrenia, bipolar disorder, depression and anxiety, and many other less common conditions. There is advice on prescribing in children and adolescents, in substance misuse and in special patient groups.  This world-renowned guide has been written in concise terms by an expert team of psychiatrists and specialist pharmacists. The Guidelines help with complex prescribing problems and include information on prescribing psychotropic medications outside their licensed indications as well as potential interactions with other medications and  substances such as alcohol, tobacco and caffeine. In addition, each of the book’s 165 sections features a full reference list so that evidence on which guidance is based can be readily accessed. This important text: Is the world’s leading clinical resource for evidence-based prescribing in day-to-day clinical practice and for formulating prescribing policy Includes referenced information on topics such as transferring from one medication to another, prescribing psychotropic medications during pregnancy or breastfeeding, and treating patients with comorbid physical conditions, including impaired renal or hepatic function. Presents guidance on complex clinical problems that may not be encountered routinely Written for psychiatrists, neuropharmacologists, pharmacists and clinical psychologists as well as nurses and medical trainees, The Maudsley Prescribing Guidelines in Psychiatry are the established reference source for ensuring the safe and effective use of medications for patients presenting with mental health problems. 
Part 1:  Drug treatment of major psychiatric conditions Chapter 1:  Schizophrenia and related psychoses ANTIPSYCHOTIC DRUGS General introduction General principles of prescribing Minimum effective doses Licensed maximum doses Equivalent doses High-dose antipsychotics: prescribing and monitoring Combined antipsychotics Antipsychotic prophylaxis Negative symptoms Monitoring Relative adverse effects – a rough guide Treatment algorithms for schizophrenia First-generation antipsychotics – place in therapy NICE guidelines for the treatment of schizophrenia Antipsychotic response – to increase the dose, to switch, to add or just wait – what is the right move? Acutely disturbed or violent behaviour Antipsychotic long-acting injections Depot antipsychotics – pharmacokinetics Management of patients on long-term depots Aripiprazole long-acting injection Olanzapine long-acting injection Paliperidone palmitate long-acting injection Risperidone long-acting injection Omega-3 fatty acid (fish oils) in schizophrenia ANTIPSYCHOTIC ADVERSE EFFECTS Extrapyramidal symptoms Akathisia Weight gain Treatment of antipsychotic-induced weight gain Electroconvulsive therapy and psychosis Neuroleptic malignant syndrome Catatonia QT prolongation Dyslipidaemia Diabetes and impaired glucose tolerance Blood pressure changes Hyponatraemia Hyperprolactinaemia Sexual dysfunction Pneumonia Switching antipsychotics Venous thromboembolism REFRACTORY SCHIZOPHRENIA AND CLOZAPINE Clozapine initiation schedule Optimising clozapine treatment Alternatives to clozapine Re-starting clozapine after a break in treatment Initiation of clozapine for community-based patients CLOZAPINE ADVERSE EFFECTS Clozapine: common adverse effects Clozapine: uncommon or unusual adverse effects Clozapine: serious haematological and cardiovascular adverse effects Clozapine-induced hypersalivation Clozapine-induced gastrointestinal hypomotility (CIGH) Clozapine, neutropenia and lithium Clozapine and chemotherapy Chapter 2:  Bipolar disorder Lithium Valproate Carbamazepine Antipsychotic drugs in bipolar disorder Antipsychotic long-acting injections in bipolar disorder Physical monitoring for people with bipolar disorder Treatment of acute mania or hypomania Rapid-cycling bipolar disorder Bipolar depression Prophylaxis in bipolar disorder Chapter 3:  Depression and anxiety disorders Chapter 4 Addictions and substance misuse Introduction Alcohol dependence Opioid dependence Nicotine and smoking cessation Pharmacological treatment of dependence on stimulants GHB and GBL dependence Benzodiazepine misuse Synthetic cannabinoid receptor agonists (SCRAs) Interactions between ‘street drugs’ and prescribed psychotropic drugs Drugs of misuse – a summary Part 2:  Drug treatment of special patient groups Chapter 5 Children and adolescents Principles of prescribing practice in childhood and adolescence Depression in children and adolescents Bipolar illness in children and adolescents Psychosis in children and adolescents Anxiety disorders in children and adolescents Obsessive compulsive disorder (OCD) in children and adolescents Post-traumatic stress disorder in children and adolescents Attention deficit hyperactivity disorder Autism spectrum disorders Tics and Tourette’s syndrome Melatonin in the treatment of insomnia in children and adolescents Rapid tranquillisation (RT) in children and adolescents Doses of commonly used psychotropic drugs in children and adolescents Chapter 6 Prescribing in older people General principles Dementia Safer prescribing for physical conditions in dementia Management of behavioural and psychological symptoms of dementia A guide to medication doses of commonly used psychotropic drugs in older adults Covert administration of medicines within food and drink Chapter 7:  Pregnancy and breastfeeding Drug choice in pregnancy Breastfeeding Chapter 8:  Hepatic and renal impairment Hepatic impairment Renal impairment Part 3:  Prescribing in specialist conditions Chapter 9:  Drug treatment of other psychiatric conditions Borderline personality disorder Eating disorders Delirium Chapter 10:  Drug treatment of psychiatric symptoms occurring in the context of other disorders General principles of prescribing in human immunodeficiency virus (HIV) Prescribing psychotropics in HIV Epilepsy 22q11.2 Deletion syndrome Learning disabilities Huntington’s disease Multiple sclerosis Parkinson’s disease Atrial fibrillation Bariatric surgery Part 4:  Other aspects of psychotropic drug use Chapter 11 Pharmacokinetics Plasma level monitoring of psychotropic drugs Interpreting post-mortem blood concentrations Acting on clozapine plasma concentration results Psychotropic drugs and cytochrome (CYP) function Smoking and psychotropic drugs Drug interactions with alcohol Chapter 12 Other substances Caffeine Nicotine Chapter 13:  Psychotropic drugs in special conditions Psychotropic drugs in overdose Driving and psychotropic drugs Psychotropic drugs and surgery Chapter 14:  Miscellany Enhancing medication adherence Re-starting psychotropic medications after a period of non-compliance Biochemical and haematological effects of psychotropic medications Summary of psychiatric adverse effects of non-psychotropic medications Prescribing drugs outside their licensed indications (‘off-label’ prescribing) The Mental Health Act in England and Wales Site of administration of intramuscular injections
David M. Taylor BSc, MSc, PhD, FFRPS, FRPharmS, is Director of Pharmacy and Pathology at the Maudsley Hospital and Professor of Psychopharmacology at King's College, London. Thomas R. E. Barnes, MBBS, MD, FRCPsych, DSc, is Emeritus Professor of Clinical Psychiatry at Imperial College London and joint-head of the Prescribing Observatory for Mental Health at the Royal College of Psychiatrists' Centre for Quality Improvement. Allan H. Young, MB, ChB, MPhil, PhD, FRCPC, FRCPsych, is Chair of Mood Disorders and is Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the Institute of Psychiatry at King's College London, UK.
The revised 13th edition of the essential reference for the prescribing of drugs for patients with mental health disorders The revised and updated 13th edition of The Maudsley Prescribing Guidelines in Psychiatry provides up-to-date, expert guidance on prescribing practice in mental health, including drug choice, treatment of adverse effects and how to augment or switch medications. The text covers a wide range of topics including pharmacological interventions for schizophrenia, bipolar disorder, depression and anxiety, and many other less common conditions. There is advice on prescribing in children and adolescents, in substance misuse and in special patient groups. This world-renowned guide has been written in concise terms by an expert team of psychiatrists and specialist pharmacists. The Guidelines help with complex prescribing problems and include information on prescribing psychotropic medications outside their licensed indications as well as potential interactions with other medications and substances such as alcohol, tobacco and caffeine. In addition, each of the book's sections features a full reference list so the evidence on which guidance is based can be readily accessed. This important text: Is the world's leading clinical resource for evidence-based prescribing in day-to-day clinical practice and for formulating prescribing policy Includes referenced information on topics such as transferring from one medication to another, prescribing psychotropic medications during pregnancy or breastfeeding, and treating patients with comorbid physical conditions, including impaired renal or hepatic function Presents guidance on complex clinical problems that may not be encountered routinely Written for psychiatrists, neuropharmacologists, pharmacists and clinical psychologists as well as nurses and medical trainees, The Maudsley Prescribing Guidelines in Psychiatry are the established reference source for ensuring the safe and effective use of medications for patients experiencing mental health problems. Praise for previous editions: 'The Guidelines proves to be clinically useful and also accomplishes something larger. It lays out the ground rules for psychotropic prescribing without taking liberties that obfuscate the limits of our evidence… Thus, the Guidelines offers a different and refreshing perspective on prescribing, one that suggests that evidence-based, sometimes algorithmic, practices are possible, but that in situations within, and especially outside, those algorithms, decision-making is in the hands of the provider, sensitive to the patient's needs and values.' The Journal of Clinical Psychiatry 'An excellent book and a "must" for practising psychiatrists… not only will the rational prescribing of psychotropic drugs drastically improve, but, more importantly, the patient will certainly benefit.' Human Psychopharmacology 'I would regard this book as mandatory for any pharmacist directly involved in the care of patients with a psychiatric diagnosis, be they primary or secondary carer-based.' The Pharmaceutical Journal
Praise for previous editions:“This is an excellent short reference book that contains concise and clear information about psychotropic prescribing for a wide range of disorders.” – The Journal of Psychopharmacology “The Guidelines proves to be clinically useful and also accomplishes something larger. It lays out the ground rules for psychotropic prescribing without taking liberties that obfuscate the limits of our evidence… Thus, the Guidelines offers a different and refreshing perspective on prescribing, one that suggests that evidence-based, sometimes algorithmic, practices are possible, but that in situations within, and especially outside, those algorithms, decision-making is in the hands of the provider, sensitive to the patient’s needs and values.” –The Journal of Clinical Psychiatry “An excellent book and a “must” for practising psychiatrists… not only will the rational prescribing of psychotropic drugs drastically improve, but, more importantly, the patient will certainly benefit.” –Human Psychopharmacology “I would regard this book as mandatory for any pharmacist directly involved in the care of patients with a psychiatric diagnosis, be they primary or secondary carer-based.” –The Pharmaceutical Journal"This comprehensive guide.. will help nurses to be confident, sensitive and informed when discussing medication with patients and relative, exploring treatment options within their professional teams and liasing with allied health professionals." -Nursing Standard

Diese Produkte könnten Sie auch interessieren:

Lectures Notes
Lectures Notes
von: John R. Bradley, Mark Gurnell, Diana F. Wood
PDF ebook
30,99 €
Sleep Disorders in Neurology
Sleep Disorders in Neurology
von: Sebastiaan Overeem, Paul Reading
PDF ebook
91,99 €